Assoc. Prof. Dr. Fadime Canbolat | Health Research | Best Researcher Award

Assoc. Prof. Dr. Fadime Canbolat | Canakkale Onsekiz Mart University | Turkey

Assoc. Prof. Dr. Fadime Canbolat is an accomplished Associate Professor of Pharmaceutical Toxicology with over a decade of academic, research, and laboratory expertise. She has made significant contributions to pharmacology, toxicology, therapeutic drug monitoring, precision medicine, and medical biotechnology. Throughout her career, she has successfully combined teaching, research, and laboratory management roles, demonstrating strong leadership in curriculum development, analytical method validation, bioanalytical studies, and risk assessment. With a proven track record of supervising graduate students, leading research projects, and publishing in reputed journals, Assoc. Prof. Dr. Fadime Canbolat has established herself as a dedicated scholar committed to advancing pharmaceutical sciences. Her multidisciplinary background integrates toxicological analysis, pharmacogenetics, and clinical pharmacology, enabling her to contribute meaningfully to both academic and applied research domains.

Professional Profile

ORCID

GOOGLE SCHOLAR

SCOPUS

Summary of Suitability

Assoc. Prof. Dr. Fadime Canbolat is a distinguished researcher, academician, and pharmaceutical toxicologist with professional and research experience in pharmacology, toxicology, precision medicine, and therapeutic drug monitoring. Her contributions span across academic teaching, advanced laboratory research, drug validation, nanoparticle-based drug delivery systems, molecular pharmacogenetics, and risk assessment studies, making her a highly qualified candidate for the Best Researcher Award.

Education

Assoc. Prof. Dr. Fadime Canbolat holds a Ph.D. in Pharmaceutical Toxicology from Yeditepe University, where her doctoral research focused on assessing the relationship between drug levels and cytochrome P450 enzyme activities in patients with genetic polymorphisms, integrating therapeutic drug monitoring and personalized medicine approaches. She also earned a Master’s degree in Pharmacology and Toxicology from Selçuk University, where she evaluated drug use patterns and prescription costs. Additionally, she pursued another Master’s degree in Visual Communication and Design at Uskudar University, enhancing her ability to integrate scientific visualization in medical research. Her undergraduate studies in Chemistry at Selçuk University provided a strong foundation in analytical sciences, which she later applied extensively in her toxicology research and teaching.

Experience

Assoc. Prof. Dr. Fadime Canbolat is currently serving as a Faculty Member at Canakkale Onsekiz Mart University, where she teaches and mentors students in pharmaceutical toxicology, pharmacology, and forensic sciences. Previously, she spent over eight years at Uskudar University’s Clinical Pharmacogenetics & Advanced Toxicology Laboratory, where she served as Laboratory Assistant Manager and later as Quality Manager. She successfully managed validation studies for therapeutic drug monitoring, developed analytical methods for various drug molecules, and contributed to the accreditation of the Advanced Toxicology Laboratory under ISO/IEC 17025 standards. Her teaching portfolio is equally extensive, having delivered courses in neuropharmacology, toxicology, pharmacogenetics, forensic chemistry, food-drug interactions, and instrumental analysis. She has also supervised numerous graduate students, guiding them in pharmacology, toxicology, and medical biotechnology research.

Research Interests

Assoc. Prof. Dr. Fadime Canbolat research interests span across several domains, including pharmaceutical toxicology, precision medicine, therapeutic drug monitoring (TDM), cytochrome P450 enzyme phenotyping, bioanalytical method development, and medical biotechnology. She is particularly focused on the clinical application of pharmacogenetics to optimize drug therapy based on individual genetic profiles. Her work also explores nanoparticle-based drug delivery systems, green synthesis of nanoparticles for biomedical applications, and risk assessment of elemental impurities in pharmaceuticals and dietary supplements. Furthermore, she is actively involved in evaluating antioxidant activity, genotoxicity, and molecular mechanisms underlying neurodegenerative and psychiatric disorders, making her research highly interdisciplinary and clinically relevant.

Awards

Assoc. Prof. Dr. Fadime Canbolat has received several recognitions for her academic and research contributions, including invitations to serve as a reviewer and editorial board member for international journals in pharmaceutical sciences. She has successfully led multiple competitive scientific research projects funded by national and institutional bodies, including studies on nanoparticle-based drug delivery systems, neuroprotective agents, precision medicine, and risk assessments in food and pharmaceuticals. Her innovative approach to integrating advanced analytical techniques with clinical pharmacology has positioned her as a leader in her field, making her a strong candidate for prestigious research awards.

Publication Top Notes

Chitosan Nanoparticles Loaded with Quercetin and Valproic Acid: A Novel Approach for Enhancing Antioxidant Activity against Oxidative Stress in the SH-SY5Y Human Neuroblastoma Cell Line

Comparison of Normal saline, Activated Charcoal and Intravenous Lipid Emulsion in a Rat Model of Colchicine Overdose: Experimental Study

Analysis of non-carcinogenic health risk assessment of elemental impurities in vitamin C supplements

Chitosan Nanoparticle Loaded with Quercetin and Valproic Acid: A Novel Approach for Enhancing Antioxidant Activity against Oxidative Stress in SH-SY5Y Cell Line

Evaluation of the Antidepressant Effect of Propolis in Chronic Unpredictable Mild Stress-induced Depression Model in Rats

Conclusion

Assoc. Prof. Dr. Fadime Canbolat is a highly dedicated academic and researcher whose contributions to pharmaceutical toxicology and pharmacogenetics are both innovative and impactful. Her extensive experience in research, teaching, laboratory management, and quality assurance demonstrates her leadership in advancing scientific knowledge and improving clinical practices. With an exceptional record of peer-reviewed publications, project leadership, and active involvement in multidisciplinary studies, she continues to make significant contributions to precision medicine, toxicological risk assessment, and nanoparticle-based drug delivery systems. Assoc. Prof. Dr. Fadime Canbolat commitment to scientific excellence, student mentorship, and collaborative research positions her as an outstanding candidate for award nomination, reflecting her influence on the advancement of pharmaceutical sciences globally.